Table 1 Baseline patient characteristics
Characteristic | Omeprazole group (n = 303) | Pantoprazole group (n = 304) | P value |
|---|---|---|---|
Age (year) | 59.15 ± 8.75 | 58.76 ± 8.50 | 0.58 |
Male [n (%)] | 209 (69.0) | 215 (70.7) | 0.66 |
Cardiovascular risk factors | |||
BMI (kg/m2) | 25.57 ± 3.86 | 25.54 ± 3.43 | 0.92 |
Hypertension [n (%)] | 199 (65.7) | 186 (61.2) | 0.27 |
Dyslipidemia [n (%)] | 135 (44.6) | 125 (41.1) | 0.41 |
Diabetes mellitus [n (%)] | 84 (27.7) | 82 (27.0) | 0.86 |
Active smoking [n (%)] | 170 (56.1) | 171 (56.3) | 1.00 |
Previous myocardial infarction [n (%)] | 48 (15.8) | 46 (15.1) | 0.82 |
Previous transient ischemic attack/stroke [n (%)] | 27 (8.9) | 27 (8.9) | 1.00 |
Final clinical diagnosis [n (%)] | |||
UA | 262 (84.3) | 264 (86.8) | 0.90 |
NSTEMI | 42 (13.9) | 39 (12.8) | 0.72 |
Laboratory parameters | |||
WBC (×1012/L) | 7.01 ± 1.85 | 6.91 ± 1.74 | 0.48 |
RBC (×109/L) | 6.04 ± 0.34 | 4.52 ± 0.55 | 0.32 |
PLT (×1012/L) | 211.16 ± 51.24 | 210.42 ± 51.89 | 0.86 |
Hb (g/L) | 140.66 ± 15.19 | 141.24 ± 13.87 | 0.67 |
Creatinine (mg/dl) | 71.73 ± 23.13 | 69.77 ± 22.95 | 0.27 |
CRP (mmol/L) | 3.73 ± 6.47 | 4.82 ± 17.54 | 0.59 |
TNT (ng/ml) | 0.08 ± 0.32 | 0.07 ± 0.31 | 0.62 |
Blood glucose (mmol/L) | 6.40 ± 2.46 | 6.75 ± 3.39 | 0.21 |
Total cholesterol (mmol/L) | 3.88 ± 1.05 | 3.86 ± 0.99 | 0.82 |
Total triglycerides (mmol/L) | 1.97 ± 1.32 | 1.92 ± 1.42 | 0.95 |
Low-density lipoprotein cholesterol (mmol/L) | 2.18 ± 0.95 | 2.14 ± 0.87 | 0.56 |
High-density lipoprotein cholesterol (mmol/L) | 1.09 ± 0.72 | 1.11 ± 0.80 | 0.80 |
Baseline ADP-PA (%) | 60.00 ± 20.87 | 57.50 ± 19.73 | 0.13 |